Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of XTL Biopharmaceuticals (NASDAQ:XTLB) through any online brokerage.
Other companies in XTL Biopharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for XTL Biopharmaceuticals to provide a consensus price target.
The stock price for XTL Biopharmaceuticals (NASDAQ: XTLB) is $2.88 last updated August 19, 2026 at 9:29 AM EDT.
There are no upcoming dividends for XTL Biopharmaceuticals.
XTL Biopharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for XTL Biopharmaceuticals.
XTL Biopharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.